Voyager Therapeutics, Inc. 8-K

What Happened Voyager Therapeutics, Inc. (ticker: VYGR) announced its fourth quarter and full-year 2025 financial results and related corporate updates on March 9, 2026. The company furnished a press release reporting those results as Exhibit 99.1 to the Form 8‑K; the exhibit is incorporated by reference into the filing. The Form 8‑K lists Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).

Key Details

• Announcement date: March 9, 2026.
• Event: Q4 2025 and full-year 2025 financial results and corporate updates announced.
• Press release furnished as Exhibit 99.1 to the Form 8‑K and incorporated by reference.
• Filing items: Item 2.02 (results of operations/financial condition) and Item 9.01 (exhibits).

Why It Matters Earnings and year‑end financial reports give investors current data on revenue, expenses, cash position, and business progress that can influence the stock and near‑term outlook. This 8‑K points you to the company’s press release (Exhibit 99.1) for the specific numbers and operational details; investors should review that release and Voyager’s SEC filings for revenue, net income/loss, cash runway, and any clinical or corporate updates relevant to valuation and risk.